These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4629827)

  • 21. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of tri- and tetracyclic antidepressive agents on the heart and the cardiovascular system].
    Müller V; Burckhardt D
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1911-3. PubMed ID: 4438988
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
    Hahn RA; Pendleton RG; Wardell JR
    J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
    [No Abstract]   [Full Text] [Related]  

  • 24. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Propranolol therapy of juvenile hypertension].
    Goldberg S; Tomesch W; Müller E
    Z Gesamte Inn Med; 1973 Dec; 28(23):724-8. PubMed ID: 4786174
    [No Abstract]   [Full Text] [Related]  

  • 26. [Propranolol effect on hemodynamic and respiratory functional data in various submaximal stress in healthy persons].
    Sziegoleit W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Teichmann W; Enke H
    Z Gesamte Inn Med; 1973 Dec; 28(23):719-24. PubMed ID: 4786173
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of propranolol and midazolam therapy on hemodynamic parameters in rabbits.
    Wiktorowska-Owczarek A; Owczarek J; Obolewska A; Orszulak-Michalak D
    Med Sci Monit; 2000; 6(5):896-900. PubMed ID: 11208429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of propranolol in the long-term treatment of angina pectoris.
    Zeft HJ; Patterson S; Orgain ES
    Arch Intern Med; 1969 Nov; 124(5):578-83. PubMed ID: 4981283
    [No Abstract]   [Full Text] [Related]  

  • 29. Propranolol in the therapy of ischaemic heart disease with angina pectoris.
    Banerjea JC; Mukherjee SK; Mukherjee TP
    Indian Heart J; 1969 Jul; 21(3):259-72. PubMed ID: 4904075
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.
    Frohlich ED; Tarazi RC; Dustan HP
    Arch Intern Med; 1969 Jan; 123(1):1-7. PubMed ID: 5761734
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of propranolol in essential hypertension--results of a 10-year therapeutic course study].
    Dück KD; Knappe J
    Z Gesamte Inn Med; 1983 Dec; 38(23):640-4. PubMed ID: 6670340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension.
    Tsuchiya M
    Jpn Circ J; 1972 Mar; 36(3):275-88. PubMed ID: 5068095
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
    Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic effect of propranolol in permanent essential arterial hypertension].
    Weiss Y; London G; Maiz HB; Safar M; Milliez P
    Coeur Med Interne; 1974; 13(3):521-5. PubMed ID: 4434715
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of a beta-blocking drug on the effects of a psychologic stress. I. Arterial pressure, heart rate, E.C.G].
    Mathis I; Accatino G
    Boll Soc Ital Biol Sper; 1970 Apr; 46(8):405-10. PubMed ID: 4926364
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ambulatory antihypertensive therapy using the beta-receptor blockader obsidan].
    Dück KD; Knappe J; Strube G
    Z Gesamte Inn Med; 1973 Aug; 28(16):Suppl:248-51. PubMed ID: 4767603
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.